1. Home
  2. TEX vs MIRM Comparison

TEX vs MIRM Comparison

Compare TEX & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEX
  • MIRM
  • Stock Information
  • Founded
  • TEX 1933
  • MIRM 2018
  • Country
  • TEX United States
  • MIRM United States
  • Employees
  • TEX N/A
  • MIRM N/A
  • Industry
  • TEX Construction/Ag Equipment/Trucks
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEX Industrials
  • MIRM Health Care
  • Exchange
  • TEX Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • TEX 3.3B
  • MIRM 3.3B
  • IPO Year
  • TEX N/A
  • MIRM 2019
  • Fundamental
  • Price
  • TEX $50.28
  • MIRM $67.93
  • Analyst Decision
  • TEX Buy
  • MIRM Strong Buy
  • Analyst Count
  • TEX 9
  • MIRM 9
  • Target Price
  • TEX $51.44
  • MIRM $73.89
  • AVG Volume (30 Days)
  • TEX 793.4K
  • MIRM 661.2K
  • Earning Date
  • TEX 07-31-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • TEX 1.35%
  • MIRM N/A
  • EPS Growth
  • TEX N/A
  • MIRM N/A
  • EPS
  • TEX 2.67
  • MIRM N/A
  • Revenue
  • TEX $5,169,000,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • TEX $4.84
  • MIRM $36.76
  • Revenue Next Year
  • TEX $4.33
  • MIRM $17.48
  • P/E Ratio
  • TEX $18.81
  • MIRM N/A
  • Revenue Growth
  • TEX N/A
  • MIRM 62.33
  • 52 Week Low
  • TEX $31.53
  • MIRM $36.86
  • 52 Week High
  • TEX $58.66
  • MIRM $69.00
  • Technical
  • Relative Strength Index (RSI)
  • TEX 51.73
  • MIRM 82.95
  • Support Level
  • TEX $47.47
  • MIRM $50.25
  • Resistance Level
  • TEX $52.62
  • MIRM $67.45
  • Average True Range (ATR)
  • TEX 1.74
  • MIRM 2.89
  • MACD
  • TEX 0.05
  • MIRM 1.38
  • Stochastic Oscillator
  • TEX 54.56
  • MIRM 94.29

About TEX Terex Corporation

Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: